Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Investigating the impact of non-tuberculous mycobacteria (NTM) on BCG-induced trained immunity against TB
EF 2019-20
Résumé
"Tuberculosis (TB) is an airborne infectious disease caused by M. tuberculosis (Mtb). Despite the world-wide application of the Bacillus-Calmette Guerin (BCG) vaccine introduced as early as 1921, TB remains one of the top infectious killers across the world. In 2018, the WHO reported approximately 10 million people were diagnosed with TB and among which there were 1.5 million deaths. BCG is the only licensed vaccine for TB and it is known to provide up to 80% protection in cases of childhood disseminated TB, but its protection efficacy is extremely variable (0-80%) in cases of adult TB. One of the current hypotheses to explain this variability is the link to geographic location and environmental exposure to non-tuberculous mycobacteria (NTM). NTM exposure does not cause disease in healthy individuals, but previous studies have shown that exposure to NTM (e.g. M. avium) blocks the protection of BCG in murine models of TB. We have recently shown that the access of BCG into the bone marrow rewires the genetic makeup of stem cells that leads to ""training"" of innate immunity to effectively fight against infection—a concept termed trained immunity. Given the geographic correlation of low vaccine efficacy and increased prevalence of NTM, we hypothesize that exposure to NTM will erase the BCG-induced trained immunity against Mtb infection."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
429078
Name
Sadeghi Mina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the impact of non-tuberculous mycobacteria (NTM) on BCG-induced trained immunity against TB
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bcg Vaccination; Bone Marrow Derived Macrophages; Hematopoietic Stem Cells; Innate Immune Memory; Lung Infection; Murine Model; Mycobacterium Avium; Mycobacterium Tuberculosis; Non-Tuberculous Mycobacteria; Trained Immunity
Abstract
"Tuberculosis (TB) is an airborne infectious disease caused by M. tuberculosis (Mtb). Despite the world-wide application of the Bacillus-Calmette Guerin (BCG) vaccine introduced as early as 1921, TB remains one of the top infectious killers across the world. In 2018, the WHO reported approximately 10 million people were diagnosed with TB and among which there were 1.5 million deaths. BCG is the only licensed vaccine for TB and it is known to provide up to 80% protection in cases of childhood disseminated TB, but its protection efficacy is extremely variable (0-80%) in cases of adult TB. One of the current hypotheses to explain this variability is the link to geographic location and environmental exposure to non-tuberculous mycobacteria (NTM). NTM exposure does not cause disease in healthy individuals, but previous studies have shown that exposure to NTM (e.g. M. avium) blocks the protection of BCG in murine models of TB. We have recently shown that the access of BCG into the bone marrow rewires the genetic makeup of stem cells that leads to ""training"" of innate immunity to effectively fight against infection—a concept termed trained immunity. Given the geographic correlation of low vaccine efficacy and increased prevalence of NTM, we hypothesize that exposure to NTM will erase the BCG-induced trained immunity against Mtb infection."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sadeghi, Mina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~